{"id":454930,"date":"2021-03-10T10:20:08","date_gmt":"2021-03-10T15:20:08","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=454930"},"modified":"2021-03-10T10:20:08","modified_gmt":"2021-03-10T15:20:08","slug":"anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/","title":{"rendered":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">BERNARDSVILLE, N.J., March  10, 2021  (GLOBE NEWSWIRE) &#8212; Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company will be participating in multiple upcoming investor and scientific conferences. Anima will first present on a panel during the Sachs 14<sup>th<\/sup> Annual European Life Sciences CEO Forum, taking place virtually Mar. 11-15, 2021. Additionally, the company will deliver a presentation and will participate in a panel during the Targeting RNA Virtual Summit on Mar. 17, 2021.<\/p>\n<p>At the Sachs 14<sup>th<\/sup> Annual European Life Sciences CEO Forum, Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will participate on a panel titled, \u201cPlatform Technologies &amp; Novel Therapeutics Panel,\u201d on Thursday, Mar. 11 at 3:10 p.m. CET.<\/p>\n<p>During the Targeting RNA Virtual Summit, Mr. Slonim and Iris Alroy, Ph.D., Vice President of Research and Development of Anima Biotech, will present a corporate presentation on Wednesday, Mar. 17 at 9:15 a.m. ET. Additionally, Dr. Alroy will participate on a panel, titled, \u201cApproaching mRNA from different angles to target undruggable proteins,\u201d on Mar. 17 at 9:45 a.m. ET.<\/p>\n<p>\n        <strong>About Anima Biotech<\/strong>\n      <\/p>\n<p>Anima Biotech is pioneering Translation Control Therapeutics, a novel approach for the discovery of small molecules that selectively control mRNA translation as a new strategy against undruggable proteins. With our proprietary technology that emits light pulses from ribosomes, we identify drug candidates that selectively decrease or increase the translation of proteins and elucidate their mechanism of action in a new target space. Our pipeline includes programs in Fibrosis (tissue selective Collagen I translation inhibitors), Oncology (c-Myc translation inhibitors and K-Ras translation inhibitors), RSV (viral translation inhibitors), Huntington&#8217;s disease (selective inhibition of the mutant mHTT) and our $1B partnership with Lilly around several Neuroscience targets. Our science was further validated with seven patents, 15 peer reviewed publications and 17 scientific collaborations. To learn more about us, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xj4YrB97Q3sL7-oFZnVm4ezdpdBswLmPlH6BUgUwvxp8CkcpfwnCP-amkCPAHihwrUf2pGhJYZAdqCmFiqJn65TkGGAAiNA9vZ7uABYnwD4=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.animabiotech.com<\/a>\u00a0\u00a0<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Andrew Mielach <br \/>LifeSci Communications<br \/>+1.646.876.5868<br \/>amielach@lifescicomms.com<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/b06ec1fb-95ce-4915-aa45-cb1c50aada85\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BERNARDSVILLE, N.J., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company will be participating in multiple upcoming investor and scientific conferences. Anima will first present on a panel during the Sachs 14th Annual European Life Sciences CEO Forum, taking place virtually Mar. 11-15, 2021. Additionally, the company will deliver a presentation and will participate in a panel during the Targeting RNA Virtual Summit on Mar. 17, 2021. At the Sachs 14th Annual European Life Sciences CEO Forum, Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will participate on a panel titled, \u201cPlatform Technologies &amp; Novel Therapeutics Panel,\u201d on Thursday, Mar. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Anima Biotech to Present at Multiple Investor and Scientific Conferences in March&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-454930","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BERNARDSVILLE, N.J., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company will be participating in multiple upcoming investor and scientific conferences. Anima will first present on a panel during the Sachs 14th Annual European Life Sciences CEO Forum, taking place virtually Mar. 11-15, 2021. Additionally, the company will deliver a presentation and will participate in a panel during the Targeting RNA Virtual Summit on Mar. 17, 2021. At the Sachs 14th Annual European Life Sciences CEO Forum, Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will participate on a panel titled, \u201cPlatform Technologies &amp; Novel Therapeutics Panel,\u201d on Thursday, Mar. &hellip; Continue reading &quot;Anima Biotech to Present at Multiple Investor and Scientific Conferences in March&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-10T15:20:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March\",\"datePublished\":\"2021-03-10T15:20:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/\"},\"wordCount\":330,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/\",\"name\":\"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\",\"datePublished\":\"2021-03-10T15:20:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/","og_locale":"en_US","og_type":"article","og_title":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk","og_description":"BERNARDSVILLE, N.J., March 10, 2021 (GLOBE NEWSWIRE) &#8212; Anima Biotech, the leader in the discovery of small molecule drugs that selectively control mRNA translation, today announced that the company will be participating in multiple upcoming investor and scientific conferences. Anima will first present on a panel during the Sachs 14th Annual European Life Sciences CEO Forum, taking place virtually Mar. 11-15, 2021. Additionally, the company will deliver a presentation and will participate in a panel during the Targeting RNA Virtual Summit on Mar. 17, 2021. At the Sachs 14th Annual European Life Sciences CEO Forum, Yochi Slonim, Co-founder and Chief Executive Officer of Anima Biotech, will participate on a panel titled, \u201cPlatform Technologies &amp; Novel Therapeutics Panel,\u201d on Thursday, Mar. &hellip; Continue reading \"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/","og_site_name":"Market Newsdesk","article_published_time":"2021-03-10T15:20:08+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March","datePublished":"2021-03-10T15:20:08+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/"},"wordCount":330,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/","name":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==","datePublished":"2021-03-10T15:20:08+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE4NzExMyM0MDU1OTA5IzUwMDA1MjgzMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/anima-biotech-to-present-at-multiple-investor-and-scientific-conferences-in-march\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Anima Biotech to Present at Multiple Investor and Scientific Conferences in March"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=454930"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/454930\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=454930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=454930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=454930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}